ABBV LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of ABBVIE INC. Shareholders Pharmaceutical Investing
CLASS ACTION UPDATE for RIVN, SDIG and AUPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
SDIG, AUPH & LILM Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm Reminds Shareholders to Actively Participate Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm Pharmaceutical Investing
ROSEN, A LEADING LAW FIRM, Encourages AbbVie Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies AbbVie, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm Pharmaceutical Investing
AUPH LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
Aptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation Market News
Aurinia Pharmaceuticals Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm Pharmaceutical Investing
